Value-Driven Pharma Event will be the most remarkable event intended to draw together stakeholders from all over the healthcare value chain to participate in discussions estimating the metrics being used by payors to decide a drug’s “value.” The event will serve as an ideal spot to attain valuable insight on information that payors desire from clinical trials. The grand event will converse the agenda that how stakeholders can work together to display value in the best interests of patients, policy and the US healthcare system. The conference will talk about the extraordinary performance-based pricing agreement between CIGNA and Merck. Value-Driven Pharma Event is the best place to know the method to enhance product differentiation from R&D through commercialization.
The targeted visitors in the event Value-Driven Pharma Event are:
- Pharmaceutical, Biotech and Medical Device manufacturers
- Senior VPs and Directors of R&D
- Chief Pharmacy Officers
- Chief Medical Officers
- Employee Health Benefit Professionals
- Government Health officials